Previous Article | Next Article ![]()
Journal of Virology, December 2001, p. 12308-12318, Vol. 75, No. 24
Department of Microbiology and Molecular
Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226
Received 16 July 2001/Accepted 10 September 2001
Although the vaccinia virus DNA polymerase is inherently
distributive, a highly processive form of the enzyme exists within the
cytoplasm of infected cells (W. F. McDonald, N. Klemperer, and P. Traktman, Virology 234:168-175, 1997). In the accompanying report we
outline the purification of the 49-kDa A20 protein as a stoichiometric
component of the processive polymerase complex (N. Klemperer, W. McDonald, K. Boyle, B. Unger, and P. Traktman, J. Virol.
75:12298-12307, 2001). To complement this biochemical analysis,
we undertook a genetic approach to the analysis of the structure and
function of the A20 protein. Here we report the application of
clustered charge-to-alanine mutagenesis of the A20 gene. Eight mutant
viruses containing altered A20 alleles were isolated using this
approach; two of these, tsA20-6 and
tsA20-ER5, have tight temperature-sensitive phenotypes.
At the nonpermissive temperature, neither virus forms macroscopic
plaques and the yield of infectious virus is <1% of that obtained at
the permissive temperature. Both viruses show a profound defect in the
accumulation of viral DNA at the nonpermissive temperature, although
both the A20 protein and DNA polymerase accumulate to wild-type levels. Cytoplasmic extracts prepared from cells infected with the
tsA20 viruses show a defect in processive polymerase
activity; they are unable to direct the formation of RFII product using
a singly primed M13 template. In sum, these data indicate that the A20 protein plays an essential role in the viral life cycle and that viruses with A20 lesions exhibit a DNA Vaccinia virus, the prototypic
member of the poxvirus family, displays a great deal of genetic and
physical autonomy from the host. The virus replicates solely within the
cytoplasm of the host, and the 192-kb genome is thought to encode most
if not all of the functions required for genome replication, gene
expression, and virion morphogenesis. The centerpiece of the
replication apparatus is the E9 DNA polymerase, which displays
significant homology to the In this report, we describe a genetic analysis of A20 aimed at
furthering our understanding of the structure of this protein and its
role(s) in vivo. The use of conditionally lethal mutants as genetic
tools for the study of vaccinia virus has been well established
(8). Four complementation groups of ts mutants exhibiting a DNA Unfortunately, no mutants with lesions in the A20 gene were isolated in
the initial mutant collections prepared by the Condit and Ensinger
laboratories (6, 7, 13, 14). We therefore undertook
a reverse genetic approach and subjected the A20 gene to targeted
mutagenesis in an attempt to isolate a conditionally lethal allele.
These efforts were successful, and we report here that the phenotype of
the ts mutants we generated confirms that the A20 protein
plays an essential role in viral DNA replication and that its
disruption compromises the production of processive DNA polymerase activity.
(A preliminary report of this work was presented at the XIIIth
International Poxvirus Workshop, Montpellier, France, September 2000.)
Materials.
Restriction endonucleases, Taq DNA
polymerase, T4 DNA ligase, calf intestinal phosphatase, pancreatic
RNase, Escherichia coli DNA polymerase I, and DNA molecular
weight standards were purchased from either Roche Molecular
Biochemicals (Indianapolis, Ind.) or New England Biolabs, Inc.
(Beverly, Mass.) and used as specified by the manufacturer. DNase I was
obtained from Cooper Biochemicals, Inc. (West Chester, Pa.).
[35S]methionine,
32P-labeled nucleoside triphosphates (NTPs), and
[methyl-3H]thymidine were purchased
from New England Nuclear Corporation (Boston, Mass.). Lipofectamine
Plus, Geneticin (G418 sulfate), and 14C-labeled
protein molecular weight markers were acquired from GIBCO-BRL Life
Technologies (Gaithersburg, Md.) and used as specified.
Cells and viruses.
BSC40 African green monkey kidney cells
and mouse L cells were maintained as monolayer cultures in Dulbecco
modified Eagle medium (DMEM) (GIBCO-BRL, Gaithersburg, Md.) containing
5% fetal calf serum. Viral stocks of wild-type (wt) vaccinia
virus (strain WR), ts42, ts17, and ts2
and the A20 mutants described below were prepared by
ultracentrifugation of infected cytoplasmic extracts through a 36%
sucrose cushion. Titers of all viral stocks were obtained by plaque
assays performed on BSC40 cells. The permissive and nonpermissive
temperatures for analysis of ts mutants were 31.5 and
40°C, respectively.
Mutagenesis and cloning of the vaccinia virus A20 gene.
Clustered charge-to-alanine mutagenesis was performed on multiple
regions of the vaccinia virus A20 gene as summarized in Fig.
1. Mutations were introduced by overlap
PCR (11). To construct each allele, two sets of primer
pairs were used to amplify the targeted region: (i) an upstream 5'
primer (UN) and a 3' primer which introduces the
complement of the mutation (A20-XUP) and (ii) a 5' primer which
introduces the mutation (A20-XDN) and a downstream 3' primer
(DN). Both UN and
DN contain BamHI sites at their 5'
termini. PCRs performed with these primer pairs and the WR genome as a
template yielded products that overlapped by 17 nt. A mixture of these
products then served as the template for a second round of PCR
performed with corresponding upstream 5' (UN) and
downstream 3' (DN) primers. The final product was gel purified, digested with BamHI, and cloned into pUC/neo,
a plasmid containing the neomycin resistance gene under the control of
the vaccinia virus P7.5 constitutive promoter (42). All
constructs were subjected to DNA sequence analysis to confirm the
insertion of the engineered mutations and the absence of spurious
mutations. The primers used were as follows (the nucleotides changed to
direct the alanine substitutions are boldfaced, and the
BamHI sites used for cloning are underlined): A20-1, (i)
UA (5' ATGGATCCAGTCTATCATCGACAC 3') and A20-1UP (5'
TTTGCTACCGCAGCATAATAATCAGATATTGACG 3'), (ii) A20-1DN (5'
TATGCTGCGGTAGCAAATAAACCGTTTAATAT 3') and DA (5'
GCGGATCCAATATACATGAACGAG 3'); A20-2, (i)
UA and A20-2UP (5'
ACTTGCCATAGCAGCTGGTATTTGAAAAGAGT 3'), (ii) A20-2DN (5'
CAGCTGCTATGGCAAGTGCGTGTAACAAAGT 3') and DA; A20-3, (i)
UB (5' ATGGATCCGAGACGTCAATATCTG
3') and A20-3UP (5'
ATGTGGCTGCCGCTATTTCAATTTCTAAAT 3'), (ii) A20-3DN (5'
AATAGCGGCAGCCACATTATTTGACGACGA 3') and DB (5'
TAGGATCCTCGTCCTATAGTGTCT 3'); A20-4, (i)
UB and A20-4UP (5'
ATAACGCGGCGGCAAATAATGTGTCTTCCT 3'), (ii) A20-4DN (5'
ATTTGCCGCCGCGTTATACTCTATTATAGAACG 3') and DB; A20-ER, (i)
UB and A20-ERUP (5'
AAAGAGGCTGCTATAATAGAGTATAACT 3'), (ii)
A20-ERDN (5' ATTATAGCAGCCTCTTTTGATGATAAATT 3') and DB; A20-5, (i)
UB and A20-5UP (5'
GAAATGCAGCAGCAAAAGAGCGTTCTATAA 3'), (ii) A20-5DN (5'
TTTTGCTGCTGCATTTCCAAAAATATCCAT 3') and DB; A20-5ER, (i)
UB and A20-5ERUP (5'
TGCAGCAGCAAAAGAGGCTGCTATAATAGAGTATAACT 3'), (ii) A20-5ERDN (5'
ATTATAGCAGCCTCTTTTGCTGCTGCATTTCCAAAAATATCCAT 3') and DB; A20-6, (i)
UC (5' CAGGATCCTAGTGAGTACGGATTA
3') and A20-6UP (5'
TTGCCGCTGCTACTGCTACAAATGTATGTTCTC 3'), (ii) A20-6DN (5'
AGCAGTAGCAGCGGCAAACACATTTTCCATTTT 3') and DC (5'
TAGGATCCAATACCCTAACGGAG 3'); A20-7, (i)
UC and A20-7UP (5'
TTATTGCTGCTGCTACAGTTCCGGATTTAT 3'), (ii) A20-7DN (5'
TGTAGCAGCAGCAATAAAAAACCAATCAGC 3') and DC; A20-8, (i)
UC and A20-8UP (5'
TTTGCTATTGCTGCTGCTACAGTTCCGGATTTAT 3'), (ii) A20-8DN (5'
AGCAGCAGCAATAGCAAACCAATCAGCATTTGA 3') and DC.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.24.12308-12318.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Clustered Charge-to-Alanine Mutagenesis of the Vaccinia Virus A20
Gene: Temperature-Sensitive Mutants Have a DNA-Minus Phenotype
and Are Defective in the Production of Processive DNA
Polymerase Activity

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
phenotype
that is correlated with a loss in processive polymerase activity as
assayed in vitro. The vaccinia virus A20 protein can, therefore, be
considered a new member of the family of proteins (E9, B1, D4, and D5)
with essential roles in vaccinia virus DNA replication.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
and
families of eucaryotic
replicative polymerases as well as the polymerases encoded by
herpesviruses. We and others have characterized the polymerase both
genetically and biochemically (4, 5,9, 10, 12, 29-31, 36, 38,
39, 41). Temperature-sensitive (ts) alleles, mutator
and anti-mutator alleles, and mutants conferring resistance to
aphidicolin, phosphonoacetic acid, and cytosine arabinoside have been
isolated and studied. The polymerase has been overexpressed and
purified and shown to have both polymerase and proofreading exonuclease
activities. We have also shown that the enzyme is inherently
distributive in vitro, being able to catalyze the addition of <10
nucleotides (nt) per binding event when moderate levels of salt (40 mM
NaCl) or divalent cations (8 mM MgCl2) are
present (31). In sharp contrast, the cytoplasmic lysates
of infected cells are able to catalyze the addition of as many as 7,000 nt in a single binding event under the same reaction conditions
(29). We demonstrated that the protein(s) responsible for
conferring processivity on the viral polymerase was present in extracts
prepared from infected cells in which only early proteins were present
but not in extracts prepared from uninfected cells. We also
demonstrated that the vaccinia virus processivity factor had a native
molecular mass of 45 kDa. In the accompanying paper, we describe
our identification of the A20 protein as a stoichiometric component of
the processive form of the polymerase. We show that A20 and DNA
polymerase copurify through six chromatographic steps, that their
physical interaction can be confirmed by coimmunoprecipitation, and
that overexpression of both A20 and DNA polymerase leads to a
corresponding increase in the levels of processive polymerase activity
(24).
phenotype have been described;
these contain lesions in the E9 DNA polymerase, the D5 DNA-independent
nucleoside triphosphatase (NTPase), the B1 protein kinase, and the D4
uracil DNA glycosylase (16, 17, 33, 34, 36, 37, 41). Other
proteins implicated in genome replication have been identified
biochemically or by sequence analysis. These include the I3
single-strand DNA binding protein (SSB), the H6 topoisomerase, the A50
DNA ligase, the F2 dUTPase, the J3 thymidine kinase, the A48
thymidylate kinase, the F4:I4 ribonucleotide reductase, and the A22
resolvase (19, 40). The roles played by some of the latter
group have been characterized using drug-resistant mutants, deletion
mutants, or inducible recombinants.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (25K):
[in a new window]
FIG. 1.
Clustered charge-to-alanine mutagenesis of the vaccinia
virus (strain WR) A20R gene. Altered alleles of A20R encoding proteins
in which the highlighted charged residues were changed to alanine were
generated as described in Materials and Methods. The endogenous A20
allele was then replaced with the mutant allele through transient
dominant selection. Of the eight mutant viruses (vA20-1,
-2, -3, -5, -ER5, -6, -7, and -8) generated using this procedure, two
(tsA20-ER5 and tsA20-6) exhibited
temperature-sensitive phenotypes. We were unable to isolate viruses
containing mutant alleles 4 or ER, suggesting that these
mutations might be lethal and unable to support virus viability.
Transient dominant selection and isolation of mutants. The endogenous A20 allele in the viral genome was replaced with the mutant A20 alleles by transient dominant selection. Dishes (diameter, 35 mm) of BSC40 cells were infected with wt vaccinia virus at a multiplicity of infection (MOI) of 0.03 PFU/cell at 37°C. At 3 h postinfection (hpi), cells were transfected individually with 5 µg of a pUC/neo-A20 mutant construct by using the Lipofectamine Plus reagent and were shifted to 31.5°C. To select for neomycin-resistant virus generated by plasmid incorporation, Geneticin (G418) was added to the cells at 18 hpi to a final concentration of 3 mg/ml. Transfectants were harvested at 48 hpi, and neomycin-resistant viruses were isolated by two sequential rounds of plaque purification in the presence of G418. Plasmid integration was confirmed by PCR amplification of the neo gene. Subsequent plaque purifications were performed in the absence of G418 so that resolution of the tandemly duplicated A20 alleles, with the accompanying loss of the intervening neo gene, could occur. Loss of neo was confirmed by PCR. Determination of which plaques lacking neo retained the wt A20 allele and which had acquired the mutant A20 allele was accomplished by amplification and DNA sequence analysis of the A20 locus. Plaques identified as lacking neo and containing the mutant sequence were subjected to subsequent rounds of plaque purification until all progeny plaques lacked neo and contained the mutant A20 allele. These plaques were then expanded, and viral stocks were prepared. All rounds of infection were performed at 31.5°C.
Determination of 24-h viral yields. Confluent BCS40 cells were infected with either wt virus, tsA20-6, tsA20-ER5, vA20-1, vA20-2, vA20-3, vA20-5, vA20-7, or vA20-8 at an MOI of 5 and incubated at either 31.5 or 40°C. At 24 hpi, infected cells were harvested by scraping, collected by sedimentation, and resuspended in a constant volume of 10 mM Tris, pH 9.0. Cells were disrupted by three cycles of freeze-thawing and two 15-s bursts of sonication. Viral yields were then determined by plaque assays performed at 31.5°C.
Analysis of viral protein synthesis by metabolic labeling.
Confluent 35-mm plates of BSC40 cells were infected with wt virus or
tsA20-6 at an MOI of 10 at either 31.5 or 40°C. At the indicated times postinfection (2, 4, 6.5, and 8.5 hpi), cells were
rinsed with prewarmed methionine-free DMEM and then incubated with the
same medium containing 100 µCi of
[35S]methionine/ml. After 45 min, the cells
were harvested by scraping, collected by sedimentation, and resuspended
in an equal volume of phosphate-buffered saline (PBS, comprising 140 mM
NaCl, 2 mM KCl, 10 mM
Na2HPO4, 1 mM
KH2PO4 [pH 7.4]). Protein
sample buffer (final concentrations, 1% sodium dodecyl sulfate
[SDS], 1%
-mercaptoethanol, 10% glycerol, 25 mM Tris [pH 6.8])
was added to an equivalent aliquot of each sample, and cells were
thoroughly disrupted by heating at 100°C. Proteins were resolved by
electrophoresis on an SDS-10% polyacrylamide gel, and
radiolabeled proteins were visualized by autoradiography.
Quantitation of viral DNA accumulation. Dishes (diameter, 35 mm) of BSC40 cells were infected with either wt virus, tsA20-6, or tsA20-ER5 at an MOI of 5 and were maintained at 31.5 or 40°C. At 3, 6, 9, 12, and 24 hpi, cells were harvested by scraping, collected by sedimentation, washed once with PBS, and resuspended in 300 µl of loading buffer (10× SSC [1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate]-1 M ammonium acetate). Cells were then disrupted by three cycles of freeze-thawing. Lysates were diluted with an additional 450 µl of loading buffer, and a 25-µl aliquot of each sample was applied, in duplicate, to a Zeta probe membrane using a Bio-Dot microfiltration apparatus (both from Bio-Rad, Richmond, Calif.). Samples were denatured (with 1.5 M NaCl and 0.5 M NaOH) and washed twice (with 10× SSC) in situ. The membrane was then hybridized with a 32P-labeled nick-translated probe representing the HindIII E and F fragments of the vaccinia virus genome. After the membrane was washed and air dried, it was exposed to a phosphor screen overnight and data were acquired using the Storm PhosphorImager (Molecular Dynamics, Sunnyvale, Calif.). The data were then quantitated using ImageQuant software (Molecular Dynamics) and plotted using SigmaPlot (SSPS, Chicago, Ill.) software.
Determination of [3H]thymidine incorporation in tsA20-infected cells. BSC40 cells were infected with either wt virus, tsA20-6, or tsA20-ER5 at an MOI of 5 and were maintained at either 31.5 or 40°C. At the indicated times postinfection (1.5, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 7, and 8 hpi), cells were rinsed with serum-free DMEM and then incubated with DMEM containing 10 µCi of [methyl-3H]thymidine/ml (83.7 Ci/mmol). After 30 min of labeling, the medium was removed and cells were rinsed with PBS and then treated in situ with ice-cold NP-40 lysis buffer (150 mM NaCl, 20 mM Tris [pH 7.8], 1.5 mM MgCl2, 0.65% NP-40). This treatment disrupts the plasma membrane but leaves the nuclei intact and adherent to the tissue culture dish. The lysis buffer was gently removed from the dish, and the cytoplasmic nucleic acids were precipitated by adding cold trichloroacetic acid (TCA) to 10%. Precipitates were collected on GF/C glass fiber filters (Whatman, Inc., Maidstone, Kent, England) and washed extensively with ice-cold 10% TCA. [3H]thymidine incorporation was determined by scintillation counting after the addition of Ready Protein liquid scintillation cocktail (Beckman Coulter, Fullerton, Calif.).
Determination of steady-state levels of the E9 polymerase and the A20 protein. Confluent 35-mm dishes of BSC40 cells were infected with either wt virus, tsA20-6, or tsA20-ER5 at an MOI of 5. At 2, 4, and 8 hpi, cells were harvested by scraping and collected by sedimentation. Cells were washed once with PBS, resuspended in 1 mM Tris (pH 9.0), and disrupted by three cycles of freeze-thawing. Extracts were then fractionated on an SDS-10% polyacrylamide gel electrophoresis (PAGE) gel, and proteins were transferred electrophoretically to nitrocellulose filters (Schleicher & Schuell, Keene, N.H.). The blot was incubated with polyclonal sera directed against the A20 protein (24) or the E9 polymerase (28) (primary sera used at a 1:500 dilution) and subsequently with a horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:15,000 to 1:20,000) (Bio-Rad). Immunoreactive proteins were visualized by chemiluminescence using the Pierce (Rockford, Ill.) Super Signal reagents.
Preparation of vaccinia virus cell extracts for in vitro
replication assays.
BSC40 cells and mouse L cells were infected
with either wt virus, ts42 (E9 polymerase mutant),
tsA20-6, tsA20-ER5, ts17
(D5 NTPase mutant), or ts2 (B1 kinase mutant) at an MOI of
15 PFU/cell and were maintained at either 31.5 or 40°C. Hydroxyurea
(10 mM) was added to the medium when the inoculum was removed at 30 min postadsorption and was present until the cells were harvested at 6 hpi.
Cells were scraped, collected via sedimentation, washed in isotonic
buffer (10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 5 mM EDTA), and
incubated in hypotonic buffer (10 mM Tris [pH 8.0], 10 mM KCl, 5 mM
EDTA) for 10 min. Cells were then broken open with a Dounce
homogenizer, and lysates were sedimented at low speed to remove nuclei
and unbroken cells. The extract was further clarified by a second
sedimentation at 16,000 × g for 20 min at 4°C.
Glycerol was added to 12%, and aliquots were stored at
80°C until use.
Singly primed M13 replication assay.
A primed template was
constructed as described previously (31). Briefly, a
24-mer oligonucleotide primer (5' CGCCAGGGTTTTCCCAGTCACGAC 3') was annealed to ssM13mp18 at a 20:1 molar ratio. Extracts prepared from cells infected with either wt virus or ts42,
tsA20-6, tsA20-ER5, ts17, or
ts2 at the permissive or nonpermissive temperature were
prepared as described above. These extracts were then assayed for
processive DNA polymerase activity in reaction mixtures containing 10 mM Tris-Cl (pH 7.5), 40 mg of bovine serum albumin/ml, 4% glycerol, 0.1 mM EDTA, 5 mM dithiothreitol, 8 mM MgCl2, 25 fmol of primed M13 DNA, 750 ng of E. coli SSB, 60 µM
(each) dCTP, dGTP, and dATP, and 20 µM
[
-32P]TTP (5 µCi/nmol). Reaction mixtures
were preincubated with two of the four dNTPs (dCTP and dGTP) for 3 min
at 30°C, and primer extension was initiated by addition of the
remaining two dNTPs. Reaction mixtures were then incubated for 15 min,
and reactions were stopped by addition of an equal volume of 1%
SDS-40 mM EDTA. Primer extension products were fractionated on a 0.8%
agarose gel containing 0.125 µg of ethidium bromide/ml; the gel was
cast and run in 1× TBE (50 mM Tris, 50 mM boric acid, 1 mM EDTA). The agarose gel was then dried and exposed to Kodak MR film (Eastman Kodak,
Rochester, N.Y.) for autoradiography.
Computer analysis. Autoradiographic films were scanned with a SAPHIR scanner (Linotype Hell Co, Hauppauge, N.Y.) and adjusted using Adobe Photoshop (Adobe Systems, Inc., San Jose, Calif.) or Canvas 6.0 (Deneba Systems, Miami, Fla.) software. Plaque assay results were photographed using an AlphaImager (Alpha Innotech, San Leandro, Calif.) digital camera. Figures were labeled using Canvas 6.0 and printed using a Kodak 8670 dye sublimation printer.
| |
RESULTS |
|---|
|
|
|---|
To conduct a genetic analysis of how the A20 protein functions in the viral life cycle, we chose to generate altered alleles of A20 by clustered charge-to-alanine mutagenesis. This technique has been used successfully in our laboratory and in those of others to generate ts mutants of vaccinia virus and gain insight into gene function (11, 20, 21). The experimental rationale is that clusters of charged residues are apt to lie on the surface of the protein. Therefore, substitutions in these regions are likely to modulate such properties as protein-protein or protein-DNA interactions rather than to disrupt global protein folding. Our goal was to isolate viruses in which the endogenous allele of A20 had been replaced with a mutant allele that conferred a conditionally lethal phenotype.
Clustered charge-to-alanine mutagenesis of the vaccinia virus A20 gene: insertion of the altered alleles into the endogenous A20 locus by transient dominant selection. We selected multiple regions of the vaccinia virus protein (Fig. 1) for mutagenesis, based on the presence of clusters of charged residues. Using overlap PCR, we generated constructs of the A19- A20-A21 region into which the nucleotides necessary to encode alanine substitutions had been introduced. We then utilized transient dominant selection to isolate viruses in which the mutant A20 allele had replaced the endogenous allele (18). Briefly, the mutant alleles were cloned into the pUC/neo plasmid, which contains the neomycin resistance gene under the control of a constitutive vaccinia virus promoter (26). Cells infected with wt virus were transfected with these plasmids and maintained at 31.5°C in the presence of G418. To select for viruses in which the plasmid had become incorporated into the genome, two rounds of plaque purification were performed in the presence of G418. In these viruses, the drug resistance gene is flanked by the endogenous and exogenous A20 alleles. Upon removal of G418 selection, the inherently unstable tandem duplication can resolve, and recombination occurs between the two A20 alleles. This recombinational resolution leads to the excision of the neo gene and the retention of either the wt or the mutant copy of the A20 gene. Loss of the neo gene was analyzed by PCR, and those plaques that had in fact retained only the desired mutant allele of A20 were identified by DNA sequence analysis.
We attempted to generate 10 mutant viruses using the procedure described above. vA20-1, -2, -3, -ER5, -5, -6, -7, and -8 were isolated and found to be viable at 31.5°C. We were unable to isolate viruses containing targeted mutations in region 4 or in the ER region adjacent to region 5. In each of these two cases, we analyzed more than 20 resolved progeny generated from multiple neo parental viruses; all were found to be wt at the A20 locus. We concluded that the particular mutations generated in these regions of the A20 protein are lethal to the virus at 31.5°C.vA20-ER5 and vA20-6 are temperature sensitive as determined by
plaque assay and single-step growth experiments.
The eight mutants
isolated were further characterized and tested for a ts
phenotype. First, the viral stocks were titrated in parallel at 31.5 and 40°C. Two mutants, vA20-ER5, in which residues 185 to
191 were changed from ERSFDDK to AASFAAA (mutated nucleotides are boldfaced), and vA20-6, in which residues 265 to 269 were changed from
KVKKK to AVAAA, were found
to be temperature sensitive. Both mutants were unable to
form plaques at 40°C but formed plaques of normal size when
titrations were performed at 31.5°C (Fig. 2). These two mutants were henceforth
designated tsA20-ER5 and tsA20-6. The plaques
formed by the other mutants were comparable to those seen with wt virus
at both temperatures (data not shown).
|
|
tsA20-6-infected cells fail to synthesize late viral
proteins at the nonpermissive temperature.
Both tsA20-6
and tsA20-ER5 show a profound temperature sensitivity that
causes a severe arrest in the infectious cycle. To determine which
stage of the vaccinia virus life cycle was affected in these
ts mutants, we first examined the temporal profile of protein synthesis in cells infected with wt virus or tsA20-6
at the permissive and nonpermissive temperatures. After infection at an
MOI of 10, BSC40 cells were metabolically labeled with
[35S]methionine for 45 min at various times
postinfection; total cell lysates were then resolved by SDS-PAGE and
visualized by autoradiography (Fig. 4).
The expression pattern seen in cells infected with tsA20-6
at the permissive temperature is virtually identical to that seen in
wt-infected cells (Fig. 4; compare lanes 12 to 15 with lanes 2 to 5).
However, a clear defect is seen in cells infected with
tsA20-6 at the nonpermissive temperature. Although the
expression of early proteins appears to be normal (Fig. 4; compare
lanes 17 to 20 [tsA20-6] to lanes 7 to 10 [wt]), late
viral proteins are not expressed (compare lanes 19 and 20 with lanes 8 to 10, 14, and 15). Thus, at the nonpermissive temperature, tsA20-6 is apparently able to enter cells and direct the
expression of early mRNAs and proteins. However, the life cycle arrests
prior to the expression of late genes. This arrest could reflect a
defect in secondary uncoating, DNA replication, or intermediate or late gene expression.
|
DNA replication is severely impaired in tsA20-ER5-
and tsA20-6-infected cells.
To establish if the
block in tsA20-6 and tsA20-ER5 infections occurs
at the stage of DNA replication, the accumulation of viral genomes
during the infectious cycle was quantitated. Cells were infected with
either wt virus, tsA20-ER5, or tsA20-6 and maintained at either 31.5 or 40°C. At 3, 6, 9, 12, and 24 hpi, cells
were harvested and aliquots of total cellular extracts were subjected
to DNA dot blot hybridization analysis. Data were quantitated on a
phosphorimager and are shown graphically in Fig.
5. When cells were infected with wt
virus, the profile of viral DNA accumulation was similar at both
temperatures, with somewhat more DNA being accumulated at 40°C (Fig.
5A). At 9, 12, and 24 hpi, levels of DNA accumulated at 40°C
relative to those at 31.5°C were 186, 139, and 137%, respectively.
This was not true in cells infected with tsA20-ER5 or
tsA20-6. At the permissive temperature, the profile seen
after tsA20-ER5 infection was similar to that observed with
wt virus (Fig. 5C): DNA accumulation increased after 3 hpi and began to
level off after 12 hpi. In tsA20-6-infected cells, DNA
accumulation was not seen until 6 hpi and continued without leveling
off for the duration of the 24-h infection (Fig. 5B). Most importantly,
cells infected at 40°C with either ts mutant showed a
severe impairment in the accumulation of viral DNA (Fig. 5B and C). At
24 hpi, the ratio of DNA accumulation in cells infected with
tsA20-6 at 40°C to that in cells infected at 31.5°C was
17%; in cells infected with tsA20-ER5 this ratio was 7%.
These data provide compelling evidence that the lesions in the
tsA20 viruses compromise viral DNA replication.
|
|
Both the A20 and polymerase proteins accumulate normally during
nonpermissive tsA20 infections in BSC40 cells.
Having established that defects in the A20 protein cause a
DNA
phenotype, we were interested in
determining what aspect(s) of A20's functioning was impaired in these
ts alleles. To investigate whether the proteins encoded by
the tsA20-6 and tsA20-ER5 alleles were
thermolabile, we prepared extracts from BSC40 cells at 2, 4, and 8 h after infection with either wt virus, tsA20-6, or
tsA20-ER5 at the permissive or nonpermissive temperature.
Aliquots were resolved by SDS-PAGE, transferred to nitrocellulose
filters, and probed with the anti-A20 serum (Fig.
7). The temporal profiles of A20
accumulation were comparable in all of the infections, indicating that
the A20 proteins encoded by the ts alleles are not
thermolabile. The A20 protein was first detected at 4 hpi at 31.5°C
and at 2 hpi at 40°C. Interestingly, the A20 proteins encoded by the
two mutant alleles had slightly faster electrophoretic mobilities than
the wt protein (Fig. 7A; compare 4- and 8-hpi lanes for wt virus,
tsA20-6, and tsA20-ER5). We were also
interested in determining whether the lesions in the A20 protein might
cause destabilization of the E9 DNA polymerase, which could in turn compromise DNA replication. The upper half of the same blot was therefore probed with the anti-DNA polymerase antibody. The levels of
polymerase at the nonpermissive and permissive temperatures were
equivalent in cells infected with wt virus or with either of the
ts mutants. Since neither the level of the A20 protein nor
that of the DNA polymerase was affected in nonpermissive
tsA20-6 and tsA20-ER5 infections, the defect in
these infections appears to be at the level of protein function rather
than at the level of synthesis or stability.
|
Extracts prepared from cells infected with tsA20-6 or tsA20-ER5 do not direct the processive conversion of singly primed M13 DNA to the RFII form. There is, as yet, no in vitro system for poxvirus DNA replication. Nor are assays available to dissect replication in vivo, beyond the ability to monitor [3H]thymidine incorporation, accumulation of viral DNA, and resolution of replication intermediates into monomeric genomes. We have, however, previously described the ability of cytoplasmic extracts of wt-infected cells to direct processive DNA synthesis on a singly primed M13 template in vitro (29). This assay was the basis of our conclusion that processive synthesis required both the E9 polymerase and at least one other early viral protein. Activity was abolished when cells were infected with a mutant encoding a temperature-sensitive DNA polymerase (ts42). Recombinant polymerase, however, could be used to reconstitute processive activity when added back to these polymerase-deficient extracts but not when added to similarly prepared extracts of uninfected cells. The accompanying paper (24) demonstrates that extracts prepared from cells overexpressing both the A20 protein and DNA polymerase show a significant increase in processive polymerase activity over that in extracts from cells in which only the polymerase is overexpressed. These data provide provocative evidence that A20 and DNA polymerase together might constitute the processive enzyme.
As an alternative approach to analyzing the role of A20 in the generation of processive polymerase activity, we examined the abilities of cytoplasmic extracts of cells infected with tsA20-6 or tsA20-ER5 to form RFII in the same in vitro assay. BSC40 cells or mouse L cells were infected with either wt virus, ts42 (DNA polymerase mutant), tsA20-6, tsA20-ER5, ts17 (D5 NTPase mutant), or ts2 (B1 kinase mutant) and maintained at either the permissive or the nonpermissive temperature. Cytoplasmic extracts were prepared from these infected cells as described in Materials and Methods, and these extracts were then tested for the ability to direct RFII formation using a singly primed M13 template in vitro. After a 3-min preincubation reaction that allowed replication complexes to assemble at the primer-template junction, synchronous DNA synthesis was initiated and allowed to proceed for 15 min at 30°C. These reactions were performed in the presence of 8 mM MgCl2, under which conditions the free E9 polymerase is highly distributive and is unable to copy the >7-kB template in the time allotted (31). Reaction products were fractionated on a TBE-agarose gel and visualized by autoradiography. Results are shown in the upper panels of Fig. 8; both the short products generated during distributive synthesis and the full-length RFII product generated during processive synthesis are indicated. Consistent with previous results (29), extracts prepared from BSC40 or L cells infected with ts42 (E9 polymerase mutant) at either the permissive or nonpermissive temperature failed to catalyze RFII formation (Fig. 8, lanes 3 and 4). The polymerase encoded by this mutant is extremely thermolabile, and no active enzyme can be detected in vitro (28). Even the short products diagnostic of distributive synthesis are absent in these reactions. Of significant importance to the present work is the observation that extracts prepared from BSC40 or L cells infected with tsA20-6 or tsA20-ER5 also failed to form RFII (Fig. 8, lanes 5 to 8). This defect was seen with extracts prepared from cells infected at either temperature and indicates that cells infected with these A20 mutants produce no processive polymerase activity that can be assayed in vitro. It is worth noting that the short products generated by the free polymerase acting in a distributive mode are present in these reactions.
|
phenotype
in vivo, their defect is not manifested in vitro in this specific
assay, which demands only the ability to elongate a primer in a
processive fashion.
| |
DISCUSSION |
|---|
|
|
|---|
Using a biochemical approach, we identified the vaccinia virus A20 protein as a stoichiometric component of the processive form of the viral DNA polymerase (24). In this report, we undertook a complementary genetic analysis of A20 in order to better understand its structure and function in the viral life cycle. Using clustered charge-to-alanine mutagenesis, we generated 10 altered alleles of the A20 gene and attempted to isolate viruses containing each of these alleles in place of the endogenous A20 gene. We were successful in isolating eight such viruses (vA20-1, -2, -3, -5, -ER5, -6, -7, and -8). We were unable to isolate vA20-4 or vA20-ER and feel justified in concluding that these alleles are not competent to support a productive infectious cycle. Six of the other alleles (A20-1, -2, -3, -5, -7, and -8) supported virus viability and did not confer any apparent phenotype. Two alleles (A20-ER5 and A20-6), however, engendered profound temperature-sensitivity.
Since the sequence of the A20 gene does not show any significant
homology to genes other than the orthologs found in other poxviruses,
and since it does not contain any recognizable motifs, it was difficult
to predict which mutations might alter the protein in a way that would
perturb its function in vivo. One of the alleles that appeared to be
lethal to the virus, A20-4
(177DDE179
AAA), affects
a region that is somewhat conserved among chordopoxvirus genomes; these
three charged residues are flanked by two invariant aromatic residues.
It was also of interest to see that whereas the A20-ER allele
(185ERSFDDK191
AASFDDK)
appeared to be incompatible with virus viability, and the adjacent
A20-5 allele
(185ERSFAAA191) conferred
no phenotype in vivo, the two in combination (A20-ER5) (185AASFAAA191) conferred a
temperature-sensitive phenotype. This region is not highly conserved in
the A20 homologs encoded by diverse poxviruses (see reference
24) (Fig. 2A), but the presence of charged residues at the
position corresponding to
185ER186 is frequent. In
essence, the A20-5 allele serves as a partial intragenic suppressor of
the ER allele. The other allele that conferred a temperature-sensitive
phenotype, A20-6
(265KVKKK269
AVAAA),
affects a region that is fairly well conserved in the various poxvirus
homologs. Both of the ts alleles encode proteins that are
stable in vivo, which is unusual; in our experience, most proteins
encoded by ts alleles are thermolabile.
Generation of two viruses in which mutation of the A20 allele conferred a dramatic temperature-sensitive phenotype allowed us to probe the role of this protein in the viral life cycle. At the permissive temperature, the infectious cycles directed by these ts viruses were comparable to those observed with wt virus. At the nonpermissive temperature, plaque formation was abolished and the viral yield produced in a 24-h infection (at an MOI of 5) was reduced by 2 to 2.5 orders of magnitude. The viral life cycle appeared to progress normally through the expression of early proteins but then arrested at the phase of DNA replication. Dot blot hybridization analysis of viral DNA accumulation, and quantitation of [3H]thymidine incorporation, indicated that DNA synthesis was largely abolished at the nonpermissive temperature. We observed a cessation of DNA synthesis when cultures that had been infected at 31.5°C were shifted to 40°C at a time when replication had already begun, confirming that the A20 lesions have a direct impact on ongoing DNA synthesis. They do not, instead, act indirectly by inhibiting a prerequisite step such as secondary uncoating. The cessation of synthesis in the shifted cultures was not immediate, however; a lag of 30 to 60 min was typical. The presence of this lag was somewhat surprising, since many mutants with defects in key replication proteins show a fast-stop phenotype, in which ongoing DNA synthesis ceases immediately when cultures are shifted to the nonpermissive temperature (17). The lag seen with both tsA20-ER5 and tsA20-6 suggests that the mutant A20 proteins might lose function slowly upon shift to the nonpermissive temperature and/or might manifest their defect only when a new round of synthesis begins on a fresh template. The mutant proteins are not thermolabile but instead show a functional thermosensitivity; perhaps A20 undergoes a conformational change or a loss of function when it dissociates from the template after helping the polymerase complete synthesis on a given template.
The observation that tsA20-ER5 and tsA20-6 had a
profound and specific defect in viral DNA replication was fully
consistent with our purification of A20 as a major component of the
processive DNA polymerase complex. We therefore reasoned that the
DNA
phenotype would reflect an inability of the
A20/DNA polymerase complex to direct processive synthesis in vivo and
that this deficit would be retained in vitro. This hypothesis was
tested by examining the ability of extracts prepared from cells
infected with tsA20-ER5 or tsA20-6 to convert a
singly primed M13 template to the RFII product in a processive manner.
These extracts were incompetent in this assay, unlike extracts prepared
from wt-infected cells. No RFII product was seen using the extracts
prepared at 31.5 or 40°C. This constitutive absence of activity is
also characteristic of extracts prepared from cells infected with
ts42, a virus with a lesion in the DNA polymerase gene
(29). Presumably, although these mutant proteins retain
sufficient function in vivo at 31.5°C, perhaps due to the stabilizing
influence of other viral proteins or the cytoplasmic architecture, they
do not manifest this function in vitro. This is particularly striking
in the case of the tsA20 extracts, since we have shown that
both the A20 and DNA polymerase proteins are stable and are indeed
present within these extracts. Furthermore, the short products
characteristic of distributive polymerase action are formed by the
tsA20 extracts, and we have not observed any defect in the
ability of these extracts to synthesize short stretches of DNA using an
activated salmon sperm template (data not shown) (30).
Thus, the A20-ER5 and A20-6 proteins are unable to perform some or all
of the activities required in the M13 assay. Because of the relative
simplicity of this assay, we presume that it is the interaction with
the polymerase, the interaction with the DNA template, or a
hypothetical interaction(s) with other modulatory proteins that is
affected. Determination of what facet of its activity as a
likely processivity factor is incapacitated by the lesions in
tsA20-ER5 and tsA20-6 will be investigated in
future studies.
During the course of this work, the laboratories of B. Moss and S. Fields published a yeast two-hybrid analysis of interactions among the full repertoire of vaccinia virus proteins (27). In this assay, the A20 protein was shown to interact with the D5 (dNTPase) and D4 (uracil DNA glycosylase) proteins, which have been shown to play essential roles in viral DNA replication (40). These observations are provocative and warrant further investigation. An interaction with the H5 protein was also observed. The abundant H5 phosphoprotein appears to have multiple roles in the viral life cycle. H5 has been shown to stimulate the transcription of late genes in vitro (25), and several mutant alleles of H5 confer a dominant, temperature-sensitive phenotype in vivo and cause an arrest at an early stage of virion morphogenesis (11). H5 is also a substrate for the B1 protein kinase, which has been shown to be important for viral DNA replication, and appears to relocate to replication factories as DNA synthesis begins (1-3). If H5 serves as a scaffolding protein for DNA synthesis, then an interaction with A20 might prove to be important.
Subsequent to this two-hybrid analysis, the Moss laboratory also
undertook a clustered charge-to-alanine mutagenesis of the A20 gene;
their findings, as well as ours, were reported at the XIIIth
International Poxvirus Workshop (Montpellier, France, September 2000),
and their work has already been published (23). The
collections of A20 alleles generated in the two studies overlap, and
our results are in general agreement with theirs regarding the
phenotypes observed. Of note, our tsA20-ER5 virus
corresponds to mutant 185 of Ishii and Moss, and for those assays
performed in common, comparable evidence of a severe ts
DNA
phenotype was obtained.
In sum, the results presented here and in the accompanying paper (24) identify the A20 protein as playing an essential role in vaccinia virus replication. Unraveling how the A20 protein interacts with DNA, the DNA polymerase, and other modulatory viral proteins to accomplish processive and faithful replication of the genome is of significant interest. These studies will enhance our understanding of vaccinia virus biology and should also provide insight into the broader question of how microorganisms and cells accomplish the universal task of DNA replication.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by a grant to P.T. from the NIH (AI 21758). K.B. is supported by an NRSA from the Public Health Service (AI 10428).
We thank R. Tether and B. Tchizhed for technical assistance and Nancy Klemperer for discussions at the initiation of this project.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, 8701 Watertown Plank Rd., Rm. BSB-273, Milwaukee, WI 53226. Phone: (414) 456-8253. Fax: (414) 456-6535. E-mail: ptrakt{at}mcw.edu.
Present address: Department of Pathology, Harvard Medical School,
Boston, MA 02115.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Beaud, G., and R. Beaud. 1997. Preferential virosomal location of underphosphorylated H5R protein synthesized in vaccinia virus-infected cells. J. Gen. Virol 78:3297-3302[Abstract]. |
| 2. | Beaud, G., R. Beaud, and D. P. Leader. 1995. Vaccinia virus gene H5R encodes a protein that is phosphorylated by the multisubstrate vaccinia virus B1R protein kinase. J. Virol. 69:1819-1826[Abstract]. |
| 3. | Brown, N. G., D. Nick Morrice, G. Beaud, G. Hardie, and D. P. Leader. 2000. Identification of sites phosphorylated by the vaccinia virus B1R kinase in viral protein H5R. BMC Biochem. 1:2[CrossRef][Medline]. |
| 4. |
Challberg, M. D., and P. T. Englund.
1979.
Purification and properties of the deoxyribonucleic acid polymerase induced by vaccinia virus.
J. Biol. Chem.
254:7812-7819 |
| 5. |
Challberg, M. D., and P. T. Englund.
1979.
The effect of template secondary structure on vaccinia DNA polymerase.
J. Biol. Chem.
254:7820-7826 |
| 6. | Condit, R. C., and A. Motyczka. 1981. Isolation and preliminary characterization of temperature sensitive mutants of vaccinia virus. Virology 113:224-241[CrossRef][Medline]. |
| 7. | Condit, R. C., A. Motyczka, and G. Spizz. 1983. Isolation, characterization and physical mapping of temperature sensitive mutants of vaccinia virus. Virology 128:429-443[CrossRef][Medline]. |
| 8. | Condit, R. C., and E. G. Niles. 1990. Orthopoxvirus genetics. Curr. Top. Microbiol. Immunol. 163:1-39[Medline]. |
| 9. |
DeFilippes, F. M.
1984.
Effect of aphidicolin on vaccinia virus: isolation of an aphidicolin-resistant mutant.
J. Virol.
52:474-482 |
| 10. |
DeFilippes, F. M.
1989.
Site of the base change in the vaccinia virus DNA polymerase gene which confers aphidicolin resistance.
J. Virol.
63:4060-4063 |
| 11. |
DeMasi, J., and P. Traktman.
2000.
Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a temperature-sensitive mutant with a profound defect in morphogenesis.
J. Virol.
74:2393-2405 |
| 12. |
Earl, P. L.,
E. V. Jones, and B. Moss.
1986.
Homology between DNA polymerase of poxviruses, herpesviruses and adenoviruses: nucleotide sequence of the vaccinia virus DNA polymerase gene.
Proc. Natl. Acad. Sci. USA
83:3659-3663 |
| 13. |
Ensinger, M.
1982.
Isolation and genetic characterization of temperature-sensitive mutants of vaccinia virus.
J. Virol.
43:778-790 |
| 14. |
Ensinger, M., and M. Rovinsky.
1983.
Marker rescue of temperature-sensitive mutations of vaccinia virus WR: correlation of genetic and physical maps.
J. Virol.
48:419-428 |
| 15. | Evans, E., N. Klemperer, R. Ghosh, and P. Traktman. 1995. The vaccinia virus D5 protein, which is required for DNA replication, is a nucleic acid-independent nucleoside triphosphatase. J. Virol. 69:5353-5361[Abstract]. |
| 16. |
Evans, E., and P. Traktman.
1987.
Molecular genetic analysis of a vaccinia virus gene with an essential role in DNA replication.
J. Virol.
61:3152-3162 |
| 17. | Evans, E., and P. Traktman. 1992. Characterization of vaccinia virus DNA replication mutants with lesions in the D5 gene. Chromosoma 102:S72-S82[CrossRef][Medline]. |
| 18. |
Falkner, F. G., and B. Moss.
1990.
Transient dominant selection of recombinant vaccinia viruses.
J. Virol.
64:3108-3111 |
| 19. |
Garcia, A. D., and B. Moss.
2001.
Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes.
J. Virol.
75:6460-6471 |
| 20. |
Hassett, D. E., and R. C. Condit.
1994.
Targeted construction of temperature-sensitive mutations in vaccinia virus by replacing clustered charged residues with alanine.
Proc. Natl. Acad. Sci. USA
91:4554-4558 |
| 21. | Hassett, D. E., J. I. Lewis, X. Xing, L. DeLange, and R. C. Condit. 1997. Analysis of a temperature-sensitive vaccinia virus mutant in the viral mRNA capping enzyme isolated by clustered charge-to-alanine mutagenesis and transient dominant selection. Virology 238:391-409[CrossRef][Medline]. |
| 22. | Hruby, D. E. 1985. Inhibition of vaccinia virus thymidine kinase by the distal products of its own metabolic pathway. Virus Res. 2:151-156[CrossRef][Medline]. |
| 23. |
Ishii, K., and B. Moss.
2001.
Role of vaccinia virus A20R protein in DNA replication: construction and characterization of temperature-sensitive mutants.
J. Virol.
75:1656-1663 |
| 24. |
Klemperer, N.,
W. McDonald,
K. Boyle,
B. Unger, and P. Traktman.
2001.
The A20R protein is a stoichiometric component of the processive form of vaccinia virus DNA polymerase.
J. Virol.
75:12298-12307 |
| 25. |
Kovacs, G. R., and B. Moss.
1996.
The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.
J. Virol.
70:6796-6802 |
| 26. | Liu, K., B. Lemon, and P. Traktman. 1995. The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro. J. Virol. 69:7823-7834[Abstract]. |
| 27. |
McCraith, S.,
T. Holtzman,
B. Moss, and S. Fields.
2000.
Genome-wide analysis of vaccinia virus protein-protein interactions.
Proc. Natl. Acad. Sci. USA
97:4879-4884 |
| 28. |
McDonald, W. F.,
V. Crozel-Goudot, and P. Traktman.
1992.
Transient expression of the vaccinia virus DNA polymerase is an intrinsic feature of the early phase of infection and is unlinked to DNA replication and late gene expression.
J. Virol.
66:534-547 |
| 29. | McDonald, W. F., N. Klemperer, and P. Traktman. 1997. Characterization of a processive form of the vaccinia virus DNA polymerase. Virology 234:168-175[CrossRef][Medline]. |
| 30. | McDonald, W. F., and P. Traktman. 1994. Overexpression and purification of the vaccinia virus DNA polymerase. Protein Expr. Purif. 5:409-421[CrossRef][Medline]. |
| 31. |
McDonald, W. F., and P. Traktman.
1994.
Vaccinia virus DNA polymerase: in vitro analysis of parameters affecting processivity.
J. Biol. Chem.
269:31190-31197 |
| 32. | McFadden, G., and S. Dales. 1980. Biogenesis of poxviruses: preliminary characterization of conditional lethal mutants of vaccinia virus defective in DNA synthesis. Virology 103:68-79[CrossRef][Medline]. |
| 33. |
Rempel, R. E.,
M. K. Anderson,
E. Evans, and P. Traktman.
1990.
Temperature-sensitive vaccinia virus mutants identify a gene with an essential role in viral replication.
J. Virol.
64:574-583 |
| 34. |
Rempel, R. E., and P. Traktman.
1992.
Vaccinia virus B1 kinase: phenotypic analysis of temperature-sensitive mutants and enzymatic characterization of recombinant proteins.
J. Virol.
66:4413-4426 |
| 35. |
Roseman, N. A., and D. E. Hruby.
1987.
Nucleotide sequence and transcript organization of a region of the vaccinia virus genome which encodes a constitutively expressed gene required for DNA replication.
J. Virol.
61:1398-1406 |
| 36. | Sridhar, P., and R. C. Condit. 1983. Selection for ts mutations in specific vaccinia virus genes: isolation of a phosphonoacetic acid-resistant, temperature sensitive virus mutant. Virology 128:444-457[CrossRef][Medline]. |
| 37. |
Stuart, D. T.,
C. Upton,
M. A. Higman,
E. G. Niles, and G. McFadden.
1993.
A poxvirus-encoded uracil DNA glycosylase is essential for virus viability.
J. Virol.
67:2503-2512 |
| 38. |
Taddie, J. A., and P. Traktman.
1991.
Genetic characterization of the vaccinia virus DNA polymerase: identification of point mutations conferring altered drug sensitivities and reduced fidelity.
J. Virol.
65:869-879 |
| 39. |
Taddie, J. A., and P. Traktman.
1993.
Genetic characterization of the vaccinia virus DNA polymerase: cytosine arabinoside resistance requires a variable lesion conferring phosphonoacetate resistance in conjunction with an invariant mutation localized to the 3'-5' exonuclease domain.
J. Virol.
67:4323-4336 |
| 40. | Traktman, P. 1996. Poxvirus DNA replication, p. 775-798. In M. DePamphilis (ed.), DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 41. |
Traktman, P.,
M. Kelvin, and S. Pacheco.
1989.
Molecular genetic analysis of vaccinia virus DNA polymerase mutants.
J. Virol.
63:841-846 |
| 42. |
Traktman, P.,
K. Liu,
R. A. Rollins,
S. A. Jesty, and B. Unger.
2000.
Elucidating the essential role of the A14 phosphoprotein in vaccinia virus morphogenesis: construction and characterization of a tetracycline-inducible recombinant.
J. Virol.
74:3682-3695 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»